For this month’s special feature we have a selection of the GLP-1 abstracts and releases from the recent American Diabetes Association’s 74th Scientific Sessions in San Francisco. New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes New Phase 3a findings show IDegLira, the …
Read More »Monthly Archives: June 2014
Editor’s Note, GLP-1 Special Edition June 2014
The last time the ADA was in San Francisco was 2008, and there were only a few of us who had even heard of a GLP-1. This novel hormone for the first time had a synthetic duplication that could be used to help control glucose levels. This time when the …
Read More »Editor’s Note DCMS #193: Is it sugar free or isn’t it?
Sometimes life is too sweet to be true and in this week’s Disaster Averted, our patient finds out how sweet life can get if you grab the wrong bottle off the grocery shelf. Our Clinical Text looks at diabetes medications that can increase insulin production and how they figure in …
Read More »Role of the Kidney, Part 4
In this week’s Homerun Slides series, we review the Etiology of Type 2 Diabetes including Insulin Resistance and Beta-Cell Dysfunction, and we take also take a look at the San Antonio Metabolism and VAGES Studies….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #51: Pharmacotherapy of Type 2 Diabetes, Part 10
Richard S. Beaser, MD Medications that Increase Insulin Secretion: SULFONYLUREAS CLASS SUMMARY: Action: Insulin secretagogues. Initial effects are to increase insulin secretory capacity. With establishment of long-term glucose control, this increase may not persist and other extrapancreatic effects, either direct or indirect, may also occur. Required for efficacy: Some remaining …
Read More »Letter from the Editor #733
This week there is a lot of press on the use of insulin right after metformin and the increased risk of death in patients on this combination. Upon reading the entire article you see, however, that it is a retrospective review and unfortunately there is little if any data on …
Read More »Watch for our upcoming issue focusing on the 74th American Diabetes Association Scientific Sessions.
Watch for our upcoming issue focusing on the 74th American Diabetes Association Scientific Sessions.
Read More »iHealth – World’s smallest, most portable mobile glucometer
iHealth – World’s smallest, most portable mobile glucometer The meter plugs directly into any smart phone, (Android or iPhone) and displays and stores readings using the iHealth Gluco-Smart app. By displaying readings directly on the phone screen, iHealth was able to shrink the device size to just slightly larger …
Read More »25 Lowest Carbohydrate-Containing Vegetables
25 Lowest Carbohydrate-Containing Vegetables When it comes to comparing which vegetables have fewer carbohydrates it’s not necessarily an easy process since vegetables come in all sizes, shapes and serving portions. Share this tool with your patients so they can make better decisions. Do you know the lowest carb containing …
Read More »Out-of-pocket Costs for Type 2 Diabetes Patients Have Risen with Wider Uptake of Insulin Analogs
Researchers found that in 2000, patients paid median out-of-pocket costs of $19 per prescription, but that his jumped to $36 in 2010. During that time, use of human synthetic insulin dropped off (from 96% to 15%) while use of short- and long-acting analogs such as glargine, detemir, and aspart increased …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.